Oxidative damage caused by free radicals produced during catecholamine autoxidation: Protective effects of O-methylation and melatonin

Free Radical Biology and Medicine

Volumn 21, Issue 2, 1996, Pages 241-249

  Miller, Joshua W ^a   Selhub, Jacob ^b   Joseph, James A ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

Autoxidation; Dopamine; Free radicals; L Dopa; Melatonin; O Methylation; Oxygen radical absorbance capacity (ORAC) assay; Parkinson's disease

Indexed keywords

CATECHOLAMINE; COPPER SULFATE; DOPAMINE; FREE RADICAL; LEVODOPA; MELATONIN; PHYCOERYTHRIN; REACTIVE OXYGEN METABOLITE;

AGING; ARTICLE; AUTOOXIDATION; BRAIN PROTECTION; CATECHOLAMINE RELEASE; DOPAMINERGIC NERVE CELL; HOST RESISTANCE; METHYLATION; NERVE CELL NECROSIS; NERVE DEGENERATION; PARKINSON DISEASE; PRIORITY JOURNAL;

PORPHYRIDIUM CRUENTUM;

EID: 0030016523     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/0891-5849(96)00033-0     Document Type: Article

References (29)

1. 1. Bindoli, A.; Rigobello, M. P.; Deeble, D. J. Biochemical and toxicological properties of the oxidative products of catecholamines. Free Radic. Biol. Med. 13:391-405; 1992.
2. 2. Adams, J. D.; Odunze, I. N. Oxygen free radicals and Parkinson's disease. Free Radic. Biol. Med. 10:161-169; 1991.
3. 3. Olanow, C. W. An introduction to the free radical hypothesis in Parkinson's disease. Ann. Neurol. 32:S2-S9; 1992.
4. 4. Chiueh, C. C.; Miyake, H.; Peng, M-T. Role of dopamine autoxidation, hydroxyl radical generation, and calcium overload in underlying mechanisms involved in MPTP-induced Parkinsonism. In: Narabayashi, H.; Nagatsu, T.; Yanagisawa, N.; Mizuno, Y., eds. Advances in neurology, Vol. 60. New York: Raven Press, Ltd.:251-258.
5. 5. Halliwell, B. Free radicals and antioxidants: A personal view. Nutr. Rev. 52(8):253-265; 1994.
6. 6. Tan, D-X.; Chen, L-D.; Poeggeler, B.; Manchester, L. C.; Reiter, R. J. Melatonin: A potent, endogenous hydroxyl radical scavenger. Endoc. J. 1:57-60; 1993.
7. 7. Pieri, C.; Marra, M.; Moroni, F.; Recchioni, R.; Marchaselli, F. Melatonin: A peroxyl radical scavenger more effective than vitamin E. Life Sci. 55(15):PL271-PL276; 1994.
8. 8. Pierrefiche, G.; Topall, G.; Courboin, G.; Henriet, I.; Laborit, H. Antioxidant activity of melatonin in mice. Res. Commun. Chem. Pathol. Pharmacol. 80(2):211-223; 1993.
9. 9. Tan, D-X.; Poeggeler, B.; Reiter, R. J.; Chen. L-D.; Chen, S.; Manchester, L. C.; Barlow-Walden, L. R. The pineal hormone melatonin inhibits DNA-adduct formation induced by the chemical carcinogen safrole in vivo. Cancer Lett. 70:65-71; 1993.
10. 10. Tan, D-X.; Reiter, R. J.; Chen, L-D.; Poeggeler, B.; Manchester, L. C.; Barlow-Walden, L. R. Both physiological and pharmacological levels of melatonin reduce DNA adduct formation induced by the carcinogen safrole. Carcinogenesis 15(2):215-218; 1994.
11. 11. Cao, G.; Alessio, H. M.; Cutler, R. G. Oxygen-radical absorbance capacity assay for antioxidants. Free Radic. Biol. Med. 14:303-311; 1993.
12. 12. Cao, G.; Cutler, R. G. High concentrations of antioxidants may not improve defense against oxidative stress. Arch. Gerontol. Geriatr. 17:189-201; 1993.
13. 13. Daniel, W. W. Biostatistics: A foundation for the analysis in the health sciences. In: Barnett, V.; Bradley, R. A.; Hunter, J. S. eds. Wiley series in probability and mathematical statistics, 4th ed. New York: John Wiley and Sons: 1987:207-366.
14. 2+) complex: A possible mechanism of nigrostriatal cell damage. Arch. Biochem. Biophys. 283(2):334-341; 1990.
15. 15. Tanaka, M.; Sotomatsu, A.; Kanai, H.; Hirai, S. Dopa and dopamine cause cultured neuronal death in the presence of iron. J. Neurol. Sci. 101:198-203; 1991.
16. 16. Tanaka, M.; Sotomatsu, A.; Kanai, H.; Hirai, S. Combined histochemical and biochemical demonstration of nigral vulnerability to lipid peroxidation induced by DOPA and iron. Neurosci. Lett. 140:42-46; 1992.
17. 17. Ogawa, N.; Edamatsu, R.; Mizukawa, K.: Asanuma, M.; Kohno, M.; Mori, A. Degeneration of dopaminergic neurons and free radicals: possible participation of levodopa. In: Narabayashi, H.; Nagatsu, T.; Yanagisawa, N.; Mizuno, Y., eds. Advances in neurology, Vol. 60. New York: Raven Press, Ltd.:242-250.
18. 18. Axelrod, J.; Lerner, A. B. O-Methylation in the conversion of tyrosine to melanin. Bioch. Biophys. Acta 71:650-655; 3963.
19. 19. Pawelek, J. M.; Lerner, A. B. 5,6-Dihydroxyindole is a melanin precursor showing potent cytotoxicity. Nature 276:627-628; 1978.
20. 20. Prota, G. Recent advances in the chemistry of melanogenesis in mammals. J. Invest. Dermatol. 75:122-127; 1980.
21. 21. Wick, M. M. An experimental approach to the chemotherapy of melanoma. J. Invest. Dermatol. 74:63-65; 1980.
22. 22. Pavel, S.; Muskiet, F. A. J.; de Lay, L.; The, T. H.; van der Silk, W. Identification of three indolic compounds in a pigmented-melanoma cell-culture supernatant by gas chromatography-mass spectrometry. J. Cancer Res. Clin. Oncol. 105:275-279; 1983.
23. 23. Smit, N. P. M.; Pavel. S.; Kammeyer, A.; Westerhof, W. Determination of catechol O-methyltransferase activity in relation to melanin metabolism using high-performance liquid chromatography with fluorimetric detection. Anal. Biochem. 190:286-291; 1990.
24. 24. Stramentinoli, G.; Gualano, M.; Catto, E.; Algeri, S. Tissue levels of S-adenosylmethionine in aging rats. J. Gerontol. 32(4):392-394; 1977.
25. 25. Hardeland, R.; Reiter, R. J.; Poeggeler, B.; Tan, D-X. The significance of the metabolism of the neurohormone melatonin: Antioxidative protection and formation of bioactive substances. Neurosci. Biobehav. Rev. 17:347-357; 1993.
26. 26. Reiter, R. J. Pineal function during aging: Attenuation of the melatonin rhythm and its neurobiological consequences. Acta Neurobiol. Exp. Suppl. 54:31-39; 1994.
27. 27. Reiter, R. J.; Tan, D-X.; Poeggeler, B.; Menendez-Pelaez, A.; Chen. L-D.; Saarela, S. Melatonin as a free radical scavenger: Implications for aging and age-related diseases. Ann. NY Acad. Sci. 719:1-12; 1994.
28. 28. Poeggeler, B.; Reiter, R. J.; Tan, D.-X.; Chen, L-D.; Manchester, L. C. Melatonin, hydroxyl radical-mediated oxidative damage, and aging: A hypothesis. J. Pineal Res. 14:151-168; 1993.
29. 29. Reiter, R. J. The aging pineal gland and its physiological consequences. Bioessays 14(3):169-175; 1992.